Mycology 2020 a collaboration between Fungal update and BSMM

MYCOLOGY 2020 will now be MYCOLOGY 2021 and will take place on 11th & 12th June 2021

2-day virtual conference

Register now

Mycology 2020 Steering Committee Chairs:

Dr. S. G. Agrawal, BSc, FRCP, FRCPath, PhD

Senior Lecturer and Honorary Consultant, Barts Health NHS Trust & Blizard Institute, Queen Mary University of London

Professor Neil A.R Gow FRS, FMedSci, FRSE, FRSB, FAAM

Deputy Vice-Chancellor for Research and Impact and Professor of Microbiology at University of Exeter

Organising Committee: Dr. Samir Agrawal, Prof. Neil Gow, Prof. Elaine Bignell, Dr. Mansour Ceesay, Dr. Jonathan Lambourne, Dr. Rohini Manuel, Prof. Malcolm Richardson, Prof. Paul Verweij, Prof. Adilia Warris, Dr. Lewis White, Dr. Mansour Ceesay, Dr. Darius Armstong-James, Dr Rebecca Gorton, Dr. Paul Pfeffer and Dr. Duncan Wilson

The webinar “Aspergillosis and COVID-19: lessons learned in diagnosis and treatment” from Fungal Update and British Society for Medical Mycology was held on December 11th, 2020. You can still access the full recording of the webinar by registering below.

Register Here

View the posters accepted for Mycology 2021 here.
Posters and authors will be present at the meeting in June.

Programme

0930

Welcome and opening remarks

Prof. Neil Gow and Dr. Samir Agrawal

Keynote lecture
Chair: Neil Gow
0945

Host susceptibility to pathogenic fungi

Agostinho Carvalho - View Bio

Parallel 1 : Haemato-oncology 1: IFD prophylaxis and management
Chair: Samir Agrawal
1015

Cologne, Germany

Philipp Köhler - View Bio
1035

Turin, Italy

Alessandro Busca - View Bio
1055

London

Samir Agrawal - View Bio
1115

Q&A

Parallel 2 : Offered Papers
Chair: Adilia Warris
1015

Who regulates the regulator? – Kinase mediated regulation of the molecular chaperone Hsp90 and its role in fungal virulence

Stephanie Diezmann - View Bio
1035

Mitochondrial reactive oxygen species regulate macrophage antifungal responses.

Elena Shekhova - View Bio
1055

Comparative genomic analyses of A. fumigatus strains reveals disease-specific pathogenicity drivers

Sara Gago - View Bio
1115

Q&A


Parallel 1 : Invited Lecture - Haemato-Oncology 2: Is there an optimal IFD protocol?
Chair: Mansour Ceesay
1135

Haemato-Oncology 2: Is there an optimal IFD protocol?

Johan Maertens - View Bio
Parallel 2 : Offered Papers
Chair: Lewis White
1135

Cryptococcus as a model system for gene expression regulation: control of protein abundance and structure by alternate start codons and their sequence context

Edward Wallace - View Bio
1155

Gilead Fellows Talk 1: Antifungal modes of action: Old and New

Elaine Bignell

Adapting the fight against Invasive Fungal Disease (IFD) in light of a global pandemic
Chair: Lewis White
THIS SYMPOSIUM IS ORGANISED AND FULLY FUNDED BY GILEAD SCIENCES LTD
1220

Introduction from the chair

1225

Incidence and pathogenesis of invasive aspergillosis in intensive care patients with severe influenza (AspiFlu)

Dr Will Hurt
1240

The impact of COVID-19 on treating fungal disease in the ICU: A case study

Dr Matt Wise
1255

Live Q&A


1300

Lunch break


COVID-19 and invasive aspergillosis: what do we need to know?
This Symposium is organised and funded by Pfizer Ltd
1320

COVID-19 and invasive aspergillosis: what do we need to know?

Dr Neil Stone
1335

A Clinical Perspective on the Management of CAPA

Ms Haifa Lyster
13:50

Q&A


Plenary : keynote presentation - Supported by ISHAM
Chair: Malcolm Richardson
1400

Medical mycology at a cross-road: the role of international organizations

Arunaloke Chakrabarti - View Bio

Parallel 1 : Diagnostics
Chair: Lewis White
1440

Performance of different lateral flow assays for rapid detection of aspergillosis – Presentation via Skype

Martin Hoenigl - View Bio
1500

Assays for rapid detection of antifungal resistance

Paul Verweij - View Bio
1520

Next-generation sequencing for invasive fungal diseases: Applications in a clinical mycology laboratory

Julianne Kus - View Bio
1540

Q&A

Parallel 2 : Meet the Pathogen
Chair: Elaine Bignell
1440

Pneumocystis jirovecii, from the organism to the disease

Alexandre Alanio - View Bio
1500

Long-distance Immune Control by Cryptococci

Robin May - View Bio
1520

COFUN: An update on the construction and use of genome wide-knockout library in A. fumigatus

Mike Bromley - View Bio
1540

Q&A


Parallel 1
Chair: Johan Maertens
1600

Fungal adaptation in CF and CPA through parasex: How to survive without sex.

Eveline Snelders - View Bio
Parallel 2 : Flash talks
Chair: Rebecca Gorton
1600

An evaluation of the performance of the IMMY sona Aspergillus Galactomannan Lateral flow assay when testing serum to aid in the diagnosis of invasive aspergillosis.

Jessica Price - View Bio
1615

Identification Of Drug Combinations To Entrap In A Carrier For The Treatment Of Onychomycosis

Sudaxshina Murdan - View Bio
1630

Carbohydrate metabolism regulates immune responses of the oral epithelium to Candida albicans

Aize Pellon - View Bio

Interactive Case Studies
Chair: Jonathan Lambourne
16:45

Case Study 1- A stroke of bad luck

Raissa Rachman - View Bio
17:00

Case Study 2-

David Harrington

1715

Close of day 1

Day 2 Opening remarks
Parallel 1 : NGS and Mycobiome
Chair: Malcolm Richardson
0920

Microbiome-mycobiome interactions and human disease

David Moyes - View Bio
0940

Understanding the impact of genetic variation on the host response towards infection – Presentation via Skype

Oliver Kurzai - View Bio
1000

Gilead Fellows Talk 2 : Triazole resistance mechanisms in Aspergillus fumigatus: what do we learn from full genome sequencing?”

Darius Armstrong-James
1020

Q&A

Parallel 2 : Offered Papers
Chair: Paul Verweij
0920

Interdependency of host and pathogen protein persulfidation governs disease severity in experimental and human aspergilloses

Jorge Amich - View Bio
0940

Toward new insights into the role of the lung microbiota in invasive pulmonary aspergillosis

Anaïs Herivaux - View Bio
1000

Epithelial uptake of Aspergillus fumigatus spores drives efficient fungal clearance in vivo and is aberrant in Chronic Obstructive Pulmonary Disease (COPD) patients

Margherita Bertuzzi - View Bio
1020

Q&A


Keynote presentation
Chair: Neil Gow
1030

C-type lectins in anti-fungal immunity

Gordon Brown - View Bio

Fungal infections in CF and bronchiectasis
Chair: Rohini Manuel
1110

Diagnosis of fungal pathogens in CF

Andrew Jones - View Bio
1140

Sensitization in Non-Cystic Fibrosis Bronchiectasis

Micheàl Mac Aogàin - View Bio
1200

Managing non-Aspergillus mould infections

Anand Shah - View Bio
1220

Q&A


Plenary : BSMM v Fungal Update Debate
Chair: Samir Agrawal
1235

Optimal fungal management – Immunology not microbiology?

Frank Van de Veerdonk and Silke Schelenz

1315

Session sponsored by IMMY

The turning point of rapid tests for the diagnosis of invasive fungal infections

Jean-Pierre Gangneux
1330

Session sponsored by Cidara Therapeutics
Rezafungin: a Novel, Once-Weekly Echinocandin in Phase 3 Development for Treatment and Prevention of Invasive Fungal Disease.

Varun Mehra

1345

Lunch break


Plenary keynote presentation
Chair: Darius Armstrong-James
1430

Update on influenza associated aspergillosis

Frank Van de Veerdonk - View Bio

Parallel 1 : Immunity and clinical impact
Chair: Duncan Wilson
1500

SNPs and risk stratification for the clinic

Lewis White - View Bio
1520

Host response to Aspergillus in asthma and allergic lung disease

Peter Cook - View Bio
1540

Offered paper – Aspergillus fumigatus Cell Wall Promotes Apical Airway Epithelial Recruitment of Human Neutrophils

Jatin Vyas - View Bio
1600

Q&A

Parallel 2 : Oral presentations from selected abstracts
Chair: Rebecca Gorton
1500

Reverse engineering of Aspergillus pH signalling for anti-fungal drug discovery

Bethany McCann - View Bio
1520

Calcium sequestration by fungal melanin reprograms macrophage metabolism toward glycolysis and antifungal immunity

Samuel Gonçalves - View Bio
1540

Prospective evaluation of T2MR for the diagnosis of Invasive Candidiasis in ICU patients

Rebecca Gorton
1600

Q&A


1630

Plenary : Presentations of prizes for winning posters

Darius Armstrong-James
1645

Closing remarks

Samir Agrawal and Neil Gow

Abstract Submission has reopened for submission

Thank you for your entries – the committee has commented on the high quality of submissions.

Please note that all accepted abstracts will be published in the Frontiers in Cellular and Infection Microbiology supplement 

As the event has now been postponed until June 2021, abstract submission has re-opened. All successful oral and poster submissions will roll forward to June but there is an opportunity for new abstracts to be submitted. The closing deadline for poster submissions, is now 23rd April 2021. Please use the template provided and submit to hayley@pagemedical.co.uk

 

If there are any queries relating to abstract submission please contact Hayley  Brown at Page Medical on 01353 780060

Sponsors and Exhibitors

This event is sponsored in part by pharmaceutical companies.

We thank all of our sponsors for their continued support of Mycology 2021.

 

Registration

Registration options and rates are below.

The fees below include registration for both days of the virtual Mycology 2021 conference.

Previously purchased registrations will automatically be transferred to the virtual conference and further details will be sent closer to the time.  The delegate passes for the virtual conference have been reduced and so you will receive a partial refund.

 

 

£100

Standard registration

£90

Standard BSMM & / or ISHAM member

£45

Student BSMM & / or ISHAM member

£50

Trainee

£250

Commercial

conferences, conventions, exhibitions, awards dinners and corporate events

Largest dedicated conference,
events and exhibition space in central London
For information on the venue and travel please visit the QEII website
Top